Brazil is one of the most lucrative health care markets in Latin America. Backed by factors, such as strong government support and high investments, Brazilian health care market is growing at a fast pace, according to Brazil Healthcare Market Analysis, a new report added to the offering of Research and Markets. Almost all the market players have been trying to bring positive developments in health care services through proper implementation of plans and policies.
As there is effective strong demand for primary health care level drugs, such as generics, antibiotics and over-the-counter (OTC) medicines, health care expenditure is expected to grow to around $ 201.6 billion by 2013, representing a compound annual growth rate (CAGR) of around 6% during 2010-2013, the report says.
Government action to broaden horizon
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze